-
Pemivibart, sold
under the
brand name Pemgarda, is a
monoclonal antibody medication authorized for the pre-exposure
prophylaxis (prevention) of COVID‑19...
-
longer currently authorized for
emergency use in the US. In
March 2024,
pemivibart (Pemgarda), a
monoclonal antibody drug,
received an
emergency use authorization...
- COVID‑19.
Pemivibart was
developed by Invivyd. The US Food and Drug
Administration (FDA)
issued an
emergency use
authorization for
pemivibart in March...
-
Pembrolizumab Keytruda mab
humanized PD-1 Y
melanoma and
other cancers Pemivibart Pemgarda mab
human spike protein receptor binding domain (RBD) of SARS-CoV-2...
-
during the studies, not to
newer variants, such as Omicron. In
March 2024,
pemivibart, a
monoclonal antibody drug,
received an
emergency use
authorization from...
-
pemedolac (INN)
pemerid (INN)
pemetrexed (INN)
Pemgarda pemirolast (INN)
pemivibart (INN)
pemoline (INN)
pempidine (INN)
pemtumomab (INN) Pen-Vee K penamecillin...
- Imdevimab† (+casirivimab) Libivirumab§
Maftivimab Nirsevimab†
Odesivimab Pemivibart Rafivirumab§ Regavirumab§
Regdanvimab Sevirumab†
Sipavibart Sotrovimab...
